Agency Information Collection Activities: Submission for OMB Review; Comment Request, 44898-44899 [2019-18415]
Download as PDF
44898
Federal Register / Vol. 84, No. 166 / Tuesday, August 27, 2019 / Notices
Dated: August 21, 2019.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2019–18403 Filed 8–26–19; 8:45 a.m.]
BILLING CODE 6820–EP–P
Division, Office of Government Ethics;
Peter J. Constantine, Associate Solicitor,
Office of Legal Counsel, Department of
Labor; Kathleen Silbaugh, General
Counsel, Office of the General Counsel,
National Transportation Safety Board;
and David Maggi, Chief, Ethics Law and
Programs Division, Department Of
Commerce.
[FR Doc. 2019–18368 Filed 8–26–19; 8:45 am]
OFFICE OF GOVERNMENT ETHICS
BILLING CODE 6345–03–P
Updated OGE Senior Executive Service
Performance Review Board
AGENCY:
Office of Government Ethics
(OGE).
ACTION:
Centers for Medicare & Medicaid
Services
Notice.
Notice is hereby given of the
appointment of new members to OGE’s
Senior Executive Service (SES)
Performance Review Board.
DATES: This update is effective as of
August 27, 2019.
FOR FURTHER INFORMATION CONTACT:
Shelley K. Finlayson, Chief of Staff and
Program Counsel, Office of Government
Ethics, Suite 500, 1201 New York
Avenue NW, Washington, DC 20005–
3917; Telephone: 202–482–9300; TYY:
800–877–8339; FAX: 202–482–9237.
SUPPLEMENTARY INFORMATION: 5 U.S.C.
4314(c) requires each agency to
establish, in accordance with
regulations prescribed by the Office of
Personnel Management at 5 CFR part
430, subpart C and § 430.310 thereof in
particular, one or more Senior Executive
Service performance review boards. As
a small executive branch agency, OGE
has just one board. In order to ensure an
adequate level of staffing and to avoid
a constant series of recusals, the
designated members of OGE’s SES
Performance Review Board are being
drawn, as in the past, in large measure
from the ranks of other executive branch
agencies. The board shall review and
evaluate the initial appraisal of each
OGE senior executive’s performance by
his or her supervisor, along with any
recommendations in each instance to
the appointing authority relative to the
performance of the senior executive. In
accordance with 5 CFR 430.311, this
notice updates the membership of
OGE’s SES Performance Review Board
as it was last published in 82 FR 43541
(September 18, 2017).
jspears on DSK3GMQ082PROD with NOTICES
SUMMARY:
Approved: August 21, 2019.
Emory Rounds,
Director, U.S. Office of Government Ethics.
The following officials are appointed
to serve as members of OGE’s SES
Performance Review Board: Shelley K.
Finlayson, [Chair], Chief of Staff and
Program Counsel, Program Counsel
VerDate Sep<11>2014
19:12 Aug 26, 2019
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jkt 247001
[Document Identifier: CMS–10697]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by September 26,
2019.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Website address at
Website address at https://
www.cms.gov/Regulations-andGuidance/Legislation/Paper
workReductionActof1995/PRAListing.html.
1. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Medicare
Coverage of Items and Services for
Coverage with Evidence Development
(CED); Use: The CED is a paradigm
whereby Medicare covers items and
services on the condition that they are
furnished in the context of approved
clinical studies or with the collection of
additional clinical data. In making
coverage decisions involving CED, CMS
decides after a formal review of the
medical literature to cover an item or
service only in the context of an
approved clinical study or when
additional clinical data are collected to
assess the appropriateness of an item or
E:\FR\FM\27AUN1.SGM
27AUN1
Federal Register / Vol. 84, No. 166 / Tuesday, August 27, 2019 / Notices
jspears on DSK3GMQ082PROD with NOTICES
service for use with a particular
beneficiary. When an NCD requires CED
under 1862(a)(1)(E), it is because the
available evidence about a particular
item or service is insufficient to support
coverage outside the context of a welldesigned clinical research study.
Sponsors could build interim analyses
and final analyses into their study
design and communicate these results to
CMS.
Section 1142 of the Act describes the
authority of the Agency for Healthcare
Research and Quality (AHRQ) to
conduct and support research on
outcomes, effectiveness, and
appropriateness of services and
procedures to identify the most effective
and appropriate means to prevent,
diagnose, treat, and manage diseases,
disorders, and other health conditions.
That section includes a requirement that
the Secretary assure that AHRQ research
priorities under Section 1142
appropriately reflect the needs and
priorities of the Medicare program.
The coordination of AHRQ priorities
under section 1142 with the needs and
priorities of the Medicare program is
accomplished through direct
collaboration between the AHRQ and
CMS. AHRQ reviews all CED NCDs
established under Section 1862(a)(1)(E)
of the Act. Consistent with section 1142,
AHRQ also indicates its support for
clinical research studies that CMS
determines address the CED questions
and meet the general standards for CED
studies. In order for CMS (or its
designated entity) to determine if the
Medicare coverage criteria are met, as
described in our regulations, CMS (or its
designated entity) must review the
study protocol and supporting
materials, as needed. Form Number:
CMS–10697 (OMB control number:
0938-New); Frequency: Yearly; Affected
Public: Private Sector (Business or other
for-profits, Not-for-Profit Institutions);
Number of Respondents: 15; Total
Annual Responses: 15; Total Annual
Hours: 15,000. (For policy questions
regarding this collection contact Xiufen
Sui at 410–786–3136.)
Dated: August 22, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2019–18415 Filed 8–26–19; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
19:12 Aug 26, 2019
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA NUMBER: 93.568]
Reallotment of Fiscal Year 2018 Funds
for the Low Income Home Energy
Assistance Program (LIHEAP)
Division of Energy Assistance,
Office of Community Services (OCS),
Administration for Children and
Families (ACF), Department of Health
and Human Services (HHS).
ACTION: Notice of public comment.
AGENCY:
Notice is hereby given of a
preliminary determination that funds
from the fiscal year (FY) 2018 Low
Income Home Energy Assistance
Program (LIHEAP) are available for
reallotment to States, Territories, Tribes,
and Tribal Organizations that received
FY 2019 direct LIHEAP grants. No
subgrantees or other entities may apply
for these funds.
DATES: Submit comments on or before
September 26, 2019.
ADDRESSES: Comments may be
submitted to: Clarence H. Carter, Acting
Director, Office of Community Services,
Administration for Children and
Families, Department of Health and
Human Services, 330 C Street SW, 5th
Floor; Mail Room 5425; Washington, DC
20201 or via email: Clarence.Carter@
acf.hhs.gov. Comments may also be
faxed to (202) 401–5661.
FOR FURTHER INFORMATION CONTACT:
Lauren Christopher, Director, Division
of Energy Assistance, Office of
Community Services, Administration
for Children and Families, Department
of Health and Human Services, 330 C
Street SW, 5th Floor; Mail Room 5425;
Washington, DC 20201. Telephone:
(202) 401–4870. Email:
lauren.christopher@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: According
to Section 2607(b)(1) of the Low Income
Home Energy Assistance Act, (42 U.S.C.
8626(b)(1)), if the Secretary of HHS
determines as of September 1, of any
fiscal year, an amount in excess of 10
percent of the amount awarded to a
grantee for that fiscal year (excluding
Leveraging and REACH funds) will not
be used by the grantee during that fiscal
year, then the Secretary must notify the
grantee and publish a notice in the
Federal Register that such funds may be
reallotted to LIHEAP grantees during the
following fiscal year. If reallotted, the
LIHEAP block grant allocation formula
will be used to distribute the funds. No
funds may be allotted to entities that are
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
44899
not direct LIHEAP grantees during FY
2019.
It has been determined that
$1,839,128 in LIHEAP funds may be
available for reallotment during FY
2019. This determination is based on FY
2018 Carryover and Reallotment Reports
which showed that seven grantees
reported reallotment funds. These
grantees were Alaska; Five Sandoval
Indian Pueblos, INC.; Hoh Indian Tribe;
Little River Band of Ottawa Indians;
Northern Cheyenne Tribe; Three
Affiliated Tribes; and Turtle Mountain
Band of Chippewa Indians. Grantees
submitted the FY 2018 Carryover and
Reallotment Reports to the OCS, as
required by regulations applicable to
LIHEAP at 45 CFR 96.81(b).
The LIHEAP statute allows grantees
who have funds unobligated at the end
of the federal fiscal year for which they
are awarded to request that they be
allowed to carry over up to 10 percent
of their full-year allotments to the next
federal fiscal year. Funds in excess of
this amount must be returned to HHS
and are subject to reallotment under
section 2607(b)(1) of the Low Income
Home Energy Assistance Act, (42 U.S.C.
8626(b)(1)). The amount described in
this notice was reported by grantees as
unobligated FY 2018 funds in excess of
the amount that these grantees could
carry over to FY 2019.
In accordance with section 2607(b)(3)
of the Act (42 U.S.C. 8626(b)(3)),
comments will be accepted for a period
of 30 days from the date of publication
of this notice.
After considering any comments
submitted, all current LIHEAP grantees
will be notified of the final reallotment
amount redistributed to them for
obligation in FY 2019. This decision
will be published in the Federal
Register and in a Dear Colleague Letter
that gets posted to ACF’s website:
https://www.acf.hhs.gov/ocs/resource/
dear-colleagues.
If funds are reallotted, they will be
allocated in accordance with section
2604 of the Act (42 U.S.C. 8623) and
must be treated by LIHEAP grantees
receiving them as an amount
appropriated for FY 2019. As FY 2019
funds, they will be subject to all
requirements of the Act, including
section 2607(b)(2) (42 U.S.C. 8626(b)(2)),
which requires that a grantee obligate at
least 90 percent of its total block grant
allocation for a fiscal year by the end of
the fiscal year for which the funds are
appropriated, that is, by September 30,
2019.
E:\FR\FM\27AUN1.SGM
27AUN1
Agencies
[Federal Register Volume 84, Number 166 (Tuesday, August 27, 2019)]
[Notices]
[Pages 44898-44899]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18415]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10697]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by September 26, 2019.
ADDRESSES: When commenting on the proposed information collections,
please reference the document identifier or OMB control number. To be
assured consideration, comments and recommendations must be received by
the OMB desk officer via one of the following transmissions: OMB,
Office of Information and Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395-5806 OR, Email:
[email protected].
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' Website address at Website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
1. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
2. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection:
Medicare Coverage of Items and Services for Coverage with Evidence
Development (CED); Use: The CED is a paradigm whereby Medicare covers
items and services on the condition that they are furnished in the
context of approved clinical studies or with the collection of
additional clinical data. In making coverage decisions involving CED,
CMS decides after a formal review of the medical literature to cover an
item or service only in the context of an approved clinical study or
when additional clinical data are collected to assess the
appropriateness of an item or
[[Page 44899]]
service for use with a particular beneficiary. When an NCD requires CED
under 1862(a)(1)(E), it is because the available evidence about a
particular item or service is insufficient to support coverage outside
the context of a well-designed clinical research study. Sponsors could
build interim analyses and final analyses into their study design and
communicate these results to CMS.
Section 1142 of the Act describes the authority of the Agency for
Healthcare Research and Quality (AHRQ) to conduct and support research
on outcomes, effectiveness, and appropriateness of services and
procedures to identify the most effective and appropriate means to
prevent, diagnose, treat, and manage diseases, disorders, and other
health conditions. That section includes a requirement that the
Secretary assure that AHRQ research priorities under Section 1142
appropriately reflect the needs and priorities of the Medicare program.
The coordination of AHRQ priorities under section 1142 with the
needs and priorities of the Medicare program is accomplished through
direct collaboration between the AHRQ and CMS. AHRQ reviews all CED
NCDs established under Section 1862(a)(1)(E) of the Act. Consistent
with section 1142, AHRQ also indicates its support for clinical
research studies that CMS determines address the CED questions and meet
the general standards for CED studies. In order for CMS (or its
designated entity) to determine if the Medicare coverage criteria are
met, as described in our regulations, CMS (or its designated entity)
must review the study protocol and supporting materials, as needed.
Form Number: CMS-10697 (OMB control number: 0938-New); Frequency:
Yearly; Affected Public: Private Sector (Business or other for-profits,
Not-for-Profit Institutions); Number of Respondents: 15; Total Annual
Responses: 15; Total Annual Hours: 15,000. (For policy questions
regarding this collection contact Xiufen Sui at 410-786-3136.)
Dated: August 22, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2019-18415 Filed 8-26-19; 8:45 am]
BILLING CODE 4120-01-P